Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 19 - Drugs for skeletal disorders
Patents for A61P 19 - Drugs for skeletal disorders (81,981)
05/2000
05/18/2000WO1999058096A3 Analogs of 2-phthalimidinoglutaric acid and their use as inhibitors of angiogenesis
05/18/2000DE19852508A1 Use of fat-soluble substance obtained from avocado oil as an antiphlogistic, antirheumatic, antimycotic or antiscabiotic agent, or as a toothpaste, lipstick, leather treatment agent or in bandages
05/18/2000DE19848260A1 Fumarsäure-Mikrotabletten Fumaric microtablets
05/18/2000CA2351063A1 A system for administering a bioactive agent by inhalation comprising a lipid mixture comprising phosphatidylcholine
05/18/2000CA2350771A1 Chemokine .beta.-7
05/18/2000CA2350714A1 Spiro-indolines as y5 receptor antagonists
05/18/2000CA2350667A1 Cross-linked hyaluronic acids and medical uses thereof
05/18/2000CA2350235A1 Tricyclic pyrazole derivatives
05/18/2000CA2350208A1 Antrhranilic acid amides and the use thereof as medicaments
05/18/2000CA2350182A1 Connective tissue growth factor (ctgf) and methods of use
05/18/2000CA2349761A1 Corticosteroid synthesis-associated genes
05/18/2000CA2349498A1 Methods and compositions for treating or preventing peripheral neuropathies
05/18/2000CA2349445A1 Antisense oligomer
05/18/2000CA2348946A1 Cystine derivatives as therapeutic agents for matrix metalloprotease related diseases
05/18/2000CA2348934A1 Phosphinate peptide analogs for the treatment of fibrotic disorders
05/18/2000CA2348763A1 Novel compounds and medicinal use thereof
05/18/2000CA2347916A1 Inhibition of the formation of vascular hyperpermeability
05/18/2000CA2345620A1 Products and methods for brachytherapy
05/18/2000CA2345459A1 Bicyclic signal transduction inhibitors, compositions containing them & uses thereof
05/17/2000EP1001023A2 Frizzled-4, a putative Wnt-receptor
05/17/2000EP1000143A1 Frazzled nucleotide sequences, expression products, compositions and uses
05/17/2000EP1000055A1 SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS
05/17/2000EP1000051A1 Carbamyloxy compounds which inhibit leukocyte adhesion mediated by vla-4
05/17/2000EP1000035A1 Substituted 6-phenylphenanthridines
05/17/2000EP1000034A1 Substituted 6-alkylphenanthridines
05/17/2000EP1000031A1 Vitronectin receptor antagonist
05/17/2000EP1000018A2 Urokinase inhibitors
05/17/2000EP1000017A1 Il-8 receptor antagonists
05/17/2000EP1000008A1 Novel thyroid receptor ligands and method
05/17/2000EP0999843A1 Pharmaceutical compositions containing vitamin d and calcium, their preparation and therapeutic use
05/17/2000EP0999842A1 Novel substituted imidazole compounds
05/17/2000EP0791011B1 Biologically active tgf-beta1 and tgf-beta2 peptides
05/17/2000CN1253563A Nitrate esters of corticoid compounds and pharmaceutical applications thereof
05/17/2000CN1253559A Sulfonyl divalent aryl alpha-hydroxamic acid compounds
05/17/2000CN1253558A Substituted imidazoles useful in treatment of inflammatory diseases
05/17/2000CN1253557A Vitamin D3 analogs with bis C-20 side chains
05/17/2000CN1253553A Substituted phenyl derivatives, their preparation and use
05/17/2000CN1253545A Aryl sulfonamides and analogues thereof and their use in treatment of neurodegenerative diseases
05/17/2000CN1253474A Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds
05/17/2000CN1253012A Medicines for treating osteoporosis and their preparing process
05/17/2000CN1052424C Plaster for curing arthralgia-syndrome
05/17/2000CN1052415C Painless bonesetting medicine
05/17/2000CN1052409C Traditional Chinese medicinal film for curing wind-cold-wetness type of arthralgia
05/17/2000CN1052403C Process for producing active ion calcium
05/16/2000US6063804 Pyrrole compounds
05/16/2000US6063386 Recombinant multivalent M protein vaccine
05/16/2000US6063378 Therapeutic agent for herniated intervertebral disc
05/11/2000WO2000026395A2 Bovine cells expressing adenovirus essential functions for propagation of recombinant adenoviral vectors
05/11/2000WO2000026372A1 Myosin heavy chain homolog
05/11/2000WO2000026252A1 Compounds with growth hormone releasing properties
05/11/2000WO2000026245A2 Human membrane transport proteins
05/11/2000WO2000026243A2 Transmembrane 4 proteins
05/11/2000WO2000026212A1 Chromenone and chromanone derivatives as integrin inhibitors
05/11/2000WO2000026208A1 N-oxides of heterocyclic compounds with tnf and pde-iv inhibiting activity
05/11/2000WO2000026205A1 Aromatic derivatives and iron complexes thereof for the use as normalising agents of the iron level
05/11/2000WO2000026203A1 2-ureido-thiazole derivatives, process for their preparation, and their use as antitumor agents
05/11/2000WO2000026202A1 2-amino-thiazole derivatives, process for their preparation, and their use as antitumor agents
05/11/2000WO2000026201A1 Benzoylpyridazines
05/11/2000WO2000026167A1 Vitamin d analogues
05/11/2000WO2000025809A1 Compositions comprising notch receptor manipulating agents
05/11/2000WO2000025794A1 Uses of 1-amino-3-(n,n-dimethylamino)-propylidene-1,1-bisphosphonic acid
05/11/2000WO2000025791A1 Pyridin-4-yl or pyrimidin-4-yl substituted pyrazines
05/11/2000WO2000025787A1 Pharmaceutical compositions containing poly(adp-ribose) glycohydrolase inhibitors and methods of using the same
05/11/2000WO2000025777A1 SUBSTITUTED PHENETHYLSULFONES AND METHOD OF REDUCING TNFαLEVELS
05/11/2000WO2000025776A1 Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositions and methods of use
05/11/2000WO2000025774A1 Benzamide potassium channel inhibitors
05/11/2000WO2000025770A1 Carbocyclic potassium channel inhibitors
05/11/2000WO2000025769A1 Analgesic regimen
05/11/2000WO2000025602A2 Use of calcareous material for foodstuff and cosmetic material
05/11/2000WO2000008130A3 Method for preparing a cartilage cell suspension
05/11/2000WO2000006769A3 Human ccr-2 gene polymorphisms
05/11/2000DE19851184A1 N-Arylsulfonyl-aminosäure-omega-amide N-arylsulfonyl-amino-omega-amides
05/11/2000DE19850701A1 Benzoylpyridazine Benzoylpyridazine
05/11/2000CA2350052A1 Pharmaceutical compositions containing poly(adp-ribose) glycohydrolase inhibitors and methods of using the same
05/11/2000CA2349818A1 Membrane transport proteins
05/11/2000CA2349232A1 Benzoylpyridazines
05/11/2000CA2349212A1 Myosin heavy chain homolog
05/11/2000CA2348907A1 Analgesic regimen
05/11/2000CA2348499A1 Use of calcareous material for foodstuff and cosmetic material
05/11/2000CA2348446A1 Benzamide potassium channel inhibitors
05/11/2000CA2347650A1 Transmembrane 4 proteins
05/11/2000CA2347188A1 2-amino-thiazole derivatives, process for their preparation, and their use as antitumor agents
05/11/2000CA2347102A1 Compounds with growth hormone releasing properties
05/11/2000CA2347060A1 2-ureido-thiazole derivatives, process for their preparation, and their use as antitumor agents
05/11/2000CA2312430A1 N-oxides of heterocyclic compounds with tnf and pde-iv inhibiting activity
05/10/2000EP0998933A1 Process for producing pharmaceutical compositions containing diphosphonates for oral administration
05/10/2000EP0998932A1 Solid pharmaceutical dosage form containing diphosphonates or their salts and method for its production
05/10/2000EP0998460A1 Novel tetrazole derivatives
05/10/2000EP0998455A1 Dihomo-seco-cholestanes with two unsaturated bones in the side chain
05/10/2000EP0998454A2 Metalloproteinase inhibitors
05/10/2000EP0998292A2 Method for inhibiting bone resorption
05/10/2000EP0998288A1 Compositions containing capsaicin or capsaicin analogues and a local anesthetic
05/10/2000EP0998283A1 Calcilytic compounds
05/10/2000CN1252809A Modified TNF alpha molecules, DNA encoding such modified TNF alpha molecules and vaccines comprising such modified TNF alpha molecules and DNA
05/10/2000CN1252799A N-heterocyclic derivatives as NOS inhibitor
05/10/2000CN1252794A Isoxazole derivatives
05/10/2000CN1252791A Arylsecochladiene derivatives
05/10/2000CN1252790A N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
05/10/2000CN1252713A N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
05/10/2000CN1252303A Hyperostereogeny treating medicine and its preparation
1 ... 746 747 748 749 750 751 752 753 754 755 756 757 758 759 760 761 762 763 764 765 766 ... 820